Cite
429 PROGNOSTIC ROLE OF LOS OF HETEROZYGOSITY ON CHROMOSOME 18 IN PATIENTS WITH LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULTS FROM A PROSPECTIVE STUDY
MLA
Riccardo Bartoletti, et al. “429 Prognostic Role of Los of Heterozygosity on Chromosome 18 in Patients with Low-Risk Non-Muscle Invasive Bladder Cancer: Results from a Prospective Study.” European Urology Supplements, vol. 8, Mar. 2009, p. 228. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........08605223f911f92222f42158d1988764&authtype=sso&custid=ns315887.
APA
Riccardo Bartoletti, T. Tony Cai, Gabriella Nesi, Nicola Mondaini, & M. Dal Canto. (2009). 429 Prognostic Role of Los of Heterozygosity on Chromosome 18 in Patients with Low-Risk Non-Muscle Invasive Bladder Cancer: Results from a Prospective Study. European Urology Supplements, 8, 228.
Chicago
Riccardo Bartoletti, T. Tony Cai, Gabriella Nesi, Nicola Mondaini, and M. Dal Canto. 2009. “429 Prognostic Role of Los of Heterozygosity on Chromosome 18 in Patients with Low-Risk Non-Muscle Invasive Bladder Cancer: Results from a Prospective Study.” European Urology Supplements 8 (March): 228. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........08605223f911f92222f42158d1988764&authtype=sso&custid=ns315887.